KLINIQ rose 4.35% or increased by 1.50 baht to 36.00 baht, trading value 135.61 million baht at 11:19 am from the opening price of 35.75 baht, the highest price of 36.50 baht, the lowest price of 35.00 baht.
Mr Sorapon Weerametheekul, Senior Director of the Securities Analysis Department, Kasikorn Securities, said that The Clinic Plc. Clinical Medicine (KLINIQ) rebounded after a period of sharp decline on concerns that 4Q22 results will weaken due to heightened competition in the beauty enhancement industry, which is negative sentiment.
But Kasikorn Securities recently spoke with KLINIQ executives and confirmed that the 4Q22 budget was not as bad as the market expected. In addition, the opening of the country of China makes Chinese tourists come to use the service more Especially the stewardess group who used to be regular customers and one-store sales (SSSG) in the 4th quarter of 2022 were better than the previous quarter (QoQ), which is a continuous growth.
Therefore, Kasikorn Securities expects KLINIQ’s profit in 2022 to be 194 million baht, an increase of 50% from the previous year, and in 2023, it will continue to grow, expecting a profit of 240 million baht. KLINIQ’s share price at 30 baht is an investable share price with a target price of 44.00 baht
As for the Master Style Public Company Limited (MASTER) which will enter the first trading day on January 25, will MASTER, which operates a cosmetic surgery center But the business is not the same as KLINIQ, which is in the beauty business MASTER has an IPO price of 46 baht for a P/E of more than 30 times. If the price of MASTER rises, it will help pull the stock price of KLINIQ to recover as well. The price of KLINIQ has a low valuation, more than 30 times, and the market price of MASTER is expected to be around 60-65 baht when entering the market.
